Recent Study on Treatment of Glucocorticoid Steroid Resistant Chronic Inflammatory Disease with Moxa Tar | Chapter 2 | Challenges in Disease and Health Research Vol. 7

 Glucocorticoids are currently used to treat chronic inflammatory disorders such as asthma, COPD, and rheumatoid arthritis. However, many chronic inflammatory disorders, such as pulmonary fibrosis, atherosclerosis-related diseases, chronic laryngitis, and chronic muscle injury, are immune to glucocorticoids. The therapeutic capacity of glucocorticoid steroids has been exhausted, necessitating the development of new anti-inflammatory drugs or therapies. Moxa (Artemisia Argyi) is a plant that produces anti-inflammatory smoke or tar when burned. Based on some clinical trials and the author's personal observation, the author wants to present a new way (moxa tar) of treating glucocorticoid steroid resistant chronic inflammatory diseases in this article. The aim of this article is to introduce a new area and to draw researchers' attention to it in order to develop new anti-inflammatory drugs or therapies. The researchers used a crossover design in this study, in which patients act as their own controls, comparing clinical symptoms and signs before and after moxa tar treatment.

Author (s) Details

Qian Zeng
Medi7 Clinic Bentleigh, Australia.

View Book :- https://stm.bookpi.org/CDHR-V7/article/view/916

A New Anti-inflammatory Therapy for Chronic Obstructive Pulmonary Disease (COPD) | Chapter 1 | Challenges in Disease and Health Research Vol. 7

 COPD (Chronic Obstructive Pulmonary Disease) is an inflammatory lung disease that causes minor airway obstruction and tissue damage in the lung alveoli.

Inhaled bronchodilators and inhaled corticosteroids (ICS) are the mainstays of current COPD therapy (inhaled Corticosteroids). The management of inflammation is the most important aspect of COPD treatment. However, COPD inflammation is partly immune to steroid treatment. Since ICS may only temporarily reduce inflammation in COPD, it is necessary to develop new anti-inflammatory therapies or drugs.

Plant Artemisia Argyi, also known as moxa. Orthodox Chinese herbalists have used its leaves to treat a variety of ailments. To treat different diseases, dried moxa fluff is made into a stick and used to heat specific points on the patient's face. Moxibustion is the name for this treatment.

The mechanism of moxibustion, according to the author's experiments, is that the smoke or tar of the burning moxa has a special anti-inflammatory property that can treat and cure Steroid resistant chronic non-specific inflammation.

To treat 25 COPD patients, the author develops a novel anti-inflammatory treatment involving the inhalation of moxa smoke. After 1 to 2 months of therapy, 22 of 25 patients were symptom-free and remained symptom-free even after the treatment was stopped.

Author (s) Details

Qian Zeng
Medi7 Clinic Bentleigh, Australia.

View Book :- https://stm.bookpi.org/CDHR-V7/article/view/915